Award facts
Completion date
Aug 31, 2026
Originally Aug 31, 2024
Funding
$35,860,092.00 Federal
$6,096,349.34
Non-federal
Place of performance
Maryland, USA
Award details come from USAspending.gov.
Transactions
Action
Federal
Non-federal
Date
Amendment
$0
$0
Jul 29, 2025
Amendment
-$190,460
$0
Oct 1, 2024
Amendment
-$190,460
$0
Oct 1, 2024
Amendment
$0
$0
May 9, 2024
Amendment
$0
$0
May 9, 2024
Amendment
$0
$0
Feb 13, 2024
Amendment
$0
$0
Feb 13, 2024
Amendment
$0
$0
Feb 13, 2024
Amendment
$0
$0
Jan 25, 2024
Amendment
$0
$0
Jan 25, 2024
Amendment
$0
$0
Jan 25, 2024
Amendment
$0
$0
Jan 25, 2024
Amendment
$155,563
$0
Sep 21, 2023
Amendment
$155,563
$0
Sep 21, 2023
Amendment
$155,563
$0
Sep 21, 2023
Amendment
$1
$0
Sep 21, 2023
Amendment
$1,164,062
$0
Sep 20, 2023
Amendment
$1,164,062
$0
Sep 20, 2023
Amendment
$1,164,062
$0
Sep 20, 2023
Amendment
$1,164,062
$0
Sep 20, 2023
Amendment
$0
$0
Jan 11, 2023
Amendment
$0
$0
Jan 11, 2023
Amendment
$0
$0
Jan 11, 2023
Amendment
$0
$0
Jan 11, 2023
Amendment
$0
$0
Jan 11, 2023
Amendment
$0
$0
Jan 11, 2023
Amendment
$0
$0
Jan 10, 2023
Amendment
$0
$0
Jan 10, 2023
Amendment
$0
$0
Jan 10, 2023
Amendment
$0
$0
Jan 10, 2023
Amendment
$0
$0
Jan 10, 2023
Amendment
$0
$0
Jan 10, 2023
Amendment
$0
$0
Jan 10, 2023
Amendment
$1
$0
Sep 15, 2022
Amendment
$155,563
$0
Sep 15, 2022
Amendment
$155,563
$0
Sep 15, 2022
Amendment
$1
$0
Sep 15, 2022
Amendment
$1
$0
Sep 15, 2022
Amendment
$2,951,097
$0
Sep 7, 2022
Amendment
$2,951,097
$0
Sep 7, 2022
Amendment
$2,951,097
$0
Sep 7, 2022
Amendment
$0
$0
Sep 23, 2021
Amendment
$0
$0
Sep 23, 2021
Amendment
$523,792
$0
Sep 17, 2021
Amendment
$523,792
$523,792
Sep 17, 2021
Amendment
Increasing participant diversity in a 'sequenced-strategy to improve outcomes in people with knee osteoarthritis pain (skoap)
$523,792
$0
Sep 17, 2021
Amendment
$190,460
$0
Sep 8, 2021
Amendment
Increasing participant diversity in a 'sequenced-strategy to improve outcomes in people with knee osteoarthritis pain (skoap)
$190,460
$0
Sep 8, 2021
Amendment
$190,460
$190,460
Sep 8, 2021
Amendment
$155,563
$0
Aug 30, 2021
Subawards
Subrecipient
Amount
Awarded
Northwestern University
Recognizing the need for greater representation of minoritized patients in clinical trials, Northwestern University will utilize diversity supplement funds to…
$927,395
Oct 20, 2026
Wake Forest University
A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain
$1,690,602
Feb 3, 2026
University Of Utah
$677,818
Jan 8, 2026
The Regents Of The University Of Colorado
$128,261
Jul 11, 2025
University Of Washington
$224,771
Apr 24, 2025
The University Of Iowa
A sequenced-strategy for improving outcomes in patients with knee osteoarthritis
$300,547
Apr 16, 2025
Emory University
$201,743
Apr 16, 2025
The Cleveland VA Medical Research & Education Foundation
$176,450
Apr 15, 2025
Rector & Visitors Of The University Of Virginia
A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain
$176,351
Mar 12, 2025
Regents Of The University Of Minnesota
$96,313
Jan 15, 2025
Duke University
A sequenced-strategy for improving outcomes in patients with knee osteoarthritis
$205,436
Jan 14, 2025
Case Western Reserve University
Arthritis, Musculoskeletal and Skin Diseases Research
$127,541
Dec 16, 2024
Vanderbilt University Medical Center
Recognizing the need for greater representation of minoritized patients in clinical trials, Northwestern University will utilize diversity supplement funds to…
$358,988
Nov 27, 2024
University Of California, Davis
A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain
$99,881
Nov 27, 2024
University Of Florida
$138,209
Nov 18, 2024
Veterans Medical Research Foundation Of San Diego
$99,366
Nov 1, 2024
The Geneva Foundation
$92,109
Nov 1, 2024
Oregon Health & Science University
$124,488
Nov 1, 2024
Foundation For Atlanta Veterans Education And Research, Inc.
The subrecipient will be enrolling clinic patients ages 18 to 90 with a confirmed diagnosis of knee osteoarthritis per the American College of Rheumatology…
$46,469
Oct 18, 2024
University Of California, San Diego
A sequenced-strategy for improving outcomes in patients with knee osteoarthritis
$463,340
Oct 14, 2024
University Of North Carolina At Chapel Hill
A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain
$96,903
Oct 14, 2024
Brigham & Womens Hospital Inc.
A􀀃sequenced�strategy􀀃for􀀃improving􀀃outcomes􀀃in􀀃patients􀀃with􀀃knee􀀃…
$345,048
Oct 7, 2024
University Of Rochester
A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain
$55,096
Apr 26, 2023
Weill Medical College Of Cornell University
Recognizing the need for greater representation of minoritized patients in clinical trials, Northwestern University will utilize diversity supplement funds to…
$97,675
Mar 9, 2023
Wake Forest University
A sequenced-strategy for improving outcomes in patients with knee osteoarthritis
$242,267
Feb 13, 2023
University Of Maryland, Baltimore
$42,349
Feb 6, 2023
Mayo Clinic
A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain
$71,927
Feb 2, 2023
The Trustees Of Columbia University In The City Of New York
$31,736
Nov 30, 2021
Show all 28
Quick answers
Who received award UH3AR077360?
UH3AR077360 was awarded to The Johns Hopkins University by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on September 25, 2019.
How much is award UH3AR077360 worth?
$41,956,441 has been obligated on UH3AR077360: $35,860,092 in federal funding and $6,096,349 in non-federal funding.
Which agency awarded UH3AR077360?
National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) awarded UH3AR077360, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
On GovTribe
See this award's full record
Every transaction and subaward
The recipient's other awards and teaming partners
Similar grant awards
Ask GovTribe AI about this award